Skip to main content

Market Overview

J&J Investors Will Soon Be Able To Exchange Shares For Kenvue Stocks

Share:
J&J Investors Will Soon Be Able To Exchange Shares For Kenvue Stocks

Shareholders of Johnson & Johnson (NYSE:JNJ) will soon have the opportunity to exchange their shares for those of Kenvue Inc. (NYSE:KVUE), the consumer health company that spun off from J&J two months ago, CNBC reports.

What Happened: J&J, which owns nearly 90% of Kenvue shares, plans to reduce its stake through an exchange offer that could launch “as early as the coming days,” according to J&J CFO Joseph Wolk.

The split-off process will allow J&J shareholders to exchange all or a portion of their shares for Kenvue’s common stock.

See Also: Trump Media SPAC Deal: Accused Insider Traders Plead Not Guilty

Describing the split-off as the “most advantageous form of separation” for J&J, Wolk added that Kenvue will most likely have a shareholder base that wants to own its stock, after the split.

Kenvue CEO Thibaut Mongon expressed satisfaction with the shareholders’ reception of the company’s initial public offering in May.

"We see a lot of alignment among our new investors in seeing the potential of Kenvue, but I can tell you that we are fully ready to leave as a fully independent company," he said. 

Read Next: Cathie Wood’s Ark Invest Piles Taiwan Semiconductor Shares, Sells Stock Of This Tesla Rival

Johnson Johnson logo. Image By Sundry Photography Via Shutterstock


Engineered by Benzinga Neuro, Edited by
Pooja Rajkumari


The GPT-4 Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you.
Learn more.


 

Related Articles (JNJ + KVUE)

View Comments and Join the Discussion!

Posted-In: Biotech Johnson & Johnson kenvue stock swapNews Markets Media General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com